Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 36149945

Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2022 Nov 22
First author
Tang T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tang T
      type
      Author
    2. name
      Le Q
      type
      Author
    3. name
      Castro S
      type
      Author
    4. name
      Pardo L
      type
      Author
    5. name
      McKay CN
      type
      Author
    6. name
      Perkins L
      type
      Author
    7. name
      Smith J
      type
      Author
    8. name
      Kirkey D
      type
      Author
    9. name
      Abrahams C
      type
      Author
    10. name
      Bedard K
      type
      Author
    11. name
      Molina A
      type
      Author
    12. name
      Brodersen LE
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tang T
      type
      Author
    2. name
      Le Q
      type
      Author
    3. name
      Castro S
      type
      Author
    4. name
      Pardo L
      type
      Author
    5. name
      McKay CN
      type
      Author
    6. name
      Perkins L
      type
      Author
    7. name
      Smith J
      type
      Author
    8. name
      Kirkey D
      type
      Author
    9. name
      Abrahams C
      type
      Author
    10. name
      Bedard K
      type
      Author
    11. name
      Molina A
      type
      Author
    12. name
      Brodersen LE
      type
      Author
    bibliography ids
    1. nci-bib-168fc028ced777f14c523860
    book metadata
    content sha256
    c97184a73cf117a30a4788c1b9b1822ea875dc2a5d60ced0e2bf1045da3a4b96
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2022008503
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36149945
    immutable id
    pubmed:36149945@c97184a73cf117a30a4788c1b9b1822ea875dc2a5d60ced0e2bf1045da3a4b96
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    22
    name
    Blood advances
    nlm unique id
    101698425
    pages
    5933-5937
    volume
    6
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36149945
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      1a9ab873496d9702558ac5941a87cfdd3d8134c3beeda03fcf5de922d079457d
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2022 Nov 22
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36149945/
      title
      Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate.

      Preserved source evidence · Independent clinical review pending · Not medical advice